BRAF and cancer: From a comprehensive framework using aggregated gene expression data from multiple datasets, Guinney et al. studied almost 2000 colorectal cancers with known BRAF mutational status that included 200 BRAF mutant cancers and identified four consensus molecular subtypes (CMSs).